CORCEPT THERAPEUTICS INC — Director's Dealing 2012

Jun 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-06-01

Reporting Person: ROE ROBERT L (President and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-01	Common stock	M	10000	$1.19	Acquired	10000	Direct
2012-06-01	Common stock	S	10000	$4.0623	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-01	Stock option	$1.19	M	10000	Disposed	2019-03-26	Common stock (10000)	Direct

Footnotes

F1: Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $4.05 to $4.07 per share. Full information on the numbers of shares sold at each sale price is available upon request.

F2: Fully exerciseable.